dihexa fda approval status 2026 Peptide Therapy: Brain & Memory Support Dihexa Peptide - Nationwide Peptides

Provided for general solution preparation where applicable

Norleucine-YIHPF (Nle'-Ang-iV), D-Nle-YI, Acetyl-NleYIH, Gamma Amino Butyric Acid- YIH, NleYI-amide, N-hexanoic-YI-(6) aminohexanoic amide (dihexa) were synthesized by Fmoc based solid phase methods in the Harding laboratory

doi: 10.1159/000199470

(Overall Hospital Quality Star Rating Modification to Emphasize the Safety of Care Measure Group: RFI) of the CY 2025 OPPS/ASC final rule with comment period (89 FR 94514 through 94521) for additional information

Volume: Due to the high concentration (70mg), use at least 3mL - 5mL of diluent to ensure full solubility

Cagrilintide adds a separate fullness signal that tirzepatide does not hit on its own